cannabis strains high in cbd and thc

Cannabis strains high in cbd and thc

Royal Highness was initially bred as a Dancehall phenotype with an even 1:1 CBD:THC ratio, though variations can be found with higher THC percentages. Royal Highness inherited a strong energetic streak from her parent strain, and consumers report highs that are uplifting, euphoric, and even sensual.

Expect a dank, earthy perfume with light floral notes and a woody, botanical exhale that leaves behind a lingering breath of sweet berries.

Shark Shock is often bred as a therapeutic CBD flower, and in addition to high-CBD and 1:1 varieties, it can also be found with THC amounts closer to 20%. Consumers should consult with their budtenders to confirm which camp their particular Shark Shock cultivar falls into; balanced 1:1 phenotypic variations deliver highs mild enough for daytime use but still potent enough to make the day entirely memorable.

Shark Shock is a sativa-dominant hybrid bred from a backcrossed White Widow — aptly named Black Widow — and Skunk #1. Shark Shock’s genetics are couched in landrace cultivars, and as such, consumers report head and body highs that deliver upbeat vibes and a gentle, psychotropic energy.


Argyle genetics lean sharply indica, delivering the kind of mild reactions that reviewers say cast a relaxed orbit around sleepytime without leaving them KO-ed. This hybrid cultivar’s effects arrive as mellow, cotton-soft head highs that smother stress and anxiety, with loose, elastic body highs that ease superficial pain.

Expect a loud, skunky perfume complicated with notes of chocolate, wet wood, coffee, and overripe grapes, and a grassy, chocolate exhale with a lingering smack of bitter coffee.

Even-keeled, 1:1 cannabis strains are cultivars with profiles that feature balanced cannabinoid ratios, i.e. commensurate doses of both THC and CBD. While these particular cultivars might not be bred for the kind of captivating, galaxy-brained effects of higher THC strains, 1:1 strains typically deliver manageable reactions for those seeking a low-stakes psychotropic relaxation rather than a too-stoned-to-function situation.


Expect a funky skunky nose with hints of tropical fruit and a gassy exhale reminiscent of overripe pineapple.

There’s certainly no shortage of high-THC cultivars lining dispensary shelves, but to conflate higher THC percentages with a more luxurious, complex, or altogether more effective high is at best misguided and at worst, a bit dangerous. Though canna-tech advancements continue to progress the agricultural end of cannabis cultivation, high-THC cannabis and cannabis products simply aren’t designed to be enjoyed by a wide swath of users. One-to-one strains, however, can be appealing to both newcomers and seasoned potheads alike.

Interestingly, Mudge says their study did find differences between the strains when it comes to a number of previously unknown cannabinoids.

The authors think these newly discovered compounds, present in low quantities, could be what changes the human physiological response to the drug – and not THC and CBD as commonly thought.

THC is regarded as the ‘psychoactive’ compound, while CBD is more about the body high – some strains are bred to have more of one and some strains have more of the other.

In other words, consumers could be blindly choosing a product, with very little information to support their final decision.

But while there’s an abundance of anecdotal evidence to back up the claim that the highs are different, a new study reveals the chemical breakdown between all these varied strains is actually rather similar.

The marijuana industry boasts hundreds of different cannabis strains, all of which promise a unique ‘high’.

This means that when marijuana users are shopping for the perfect cannabis strain, they are being given chemical compositions that may have no effect on their physiological response.

Despite their unique and quirky street names, it appears that many strains of cannabis have virtually identical levels of THC and CBD.

“Understanding the presence of the low abundance cannabinoids could provide valuable information to the medical cannabis community,” says Mudge.